Biotech

All Articles

Rivus' stage 2 obesity-related cardiac arrest trial hits endpoint

.Rivus Pharmaceuticals has plumped up the leads of its own fat-busting, muscle-sparing drug applican...

Ovid standstills preclinical job, IV plan after soticlestat fall short

.Ovid Therapy presently showed final month that it was actually trimming its own head count as the f...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston ma Port

.Eli Lilly has actually opened up a $700 million R&ampD center in the Boston Seaport, improving its ...

Boundless Biography helps make 'reasonable' discharges five months after $100M IPO

.Only 5 months after protecting a $100 thousand IPO, Vast Bio is already laying off some employees a...

Halda's $126M will evolve 'keep as well as get rid of' growth medications

.The preliminary stages of oncology R&ampD aren't short of intriguing brand new methods, as well as ...

Lykos 'disappointments' not divulging study violations with author

.Psychopharmacology has actually pulled 3 write-ups regarding midstage scientific test data assessin...

Analysts dig into Avidity's DMD gain, revealing distinctions in records

.Avidity Biosciences satisfied capitalists with phase 1/2 data in Duchenne muscular dystrophy (DMD) ...

Actinogen's cortisol blocker neglects period 2 depression research study

.Actinogen Medical's cortisol blocker has missed the primary endpoint of a phase 2 research in anxie...

Bivictrix determines going private only means to take ADC right into clinic

.Antibody-drug conjugates (ADCs) have gone to the facility of numerous a billion-dollar biobuck lice...

TPG tops up funds to $580M for investments across lifestyle sciences

.Asset supervisor TPG, which has actually supported biotechs like Sionna Rehabs as well as Santa Cla...